Literature DB >> 14584305

Oral contraception and cyclic changes in premenstrual and menstrual experiences.

S Abraham1, G Luscombe, I Soo.   

Abstract

Despite the widespread use of oral contraceptives (OC) there is no consensus regarding their effect on menstrual cycle experiences. This study examines the cyclic changes of prospectively collected, daily menstrual cycle experiences of two groups of 'healthy women' using monophasic and triphasic OC compared with a group using non-hormonal contraception. A total of 119 'healthy women' using monophasic, triphasic or non-hormonal contraception for three months, made daily ratings over at least two complete menstrual cycles. Cyclic changes of ratings within and between the groups were analyzed. The three groups showed significant cyclic changes in abdominal fullness, abdominal discomfort, breast fullness, general 'premenstrual syndrome-like symptoms' and in at least two mood ratings. Maximal changes in ratings occurred during the late premenstrual and menstrual phases. There were no significant differences between the three groups in cyclic changes for any physical rating, but there were for tiredness or fatigue (non-OC users reported experiencing tiredness or fatigue more frequently than the OC users) and sadness or depression (non-OC users experienced sadness or depression less frequently than OC users during the early part of the cycle, followed by a sharp rise from early premenstrual to the menstrual phase). There were no significant cyclic differences in ratings between the monophasic and triphasic groups. In conclusion, 'healthy women' using OC experience premenstrual and menstrual changes. Any differences between OC formulations are subtle and not of clinical significance in 'healthy women' already established on monophasic or triphasic hormonal contraception.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14584305     DOI: 10.3109/01674820309039672

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  8 in total

1.  The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome.

Authors:  Kimberly A Yonkers; Brianna Cameron; Ralitza Gueorguieva; Margaret Altemus; Susan G Kornstein
Journal:  J Womens Health (Larchmt)       Date:  2016-11-17       Impact factor: 2.681

2.  Oral contraceptive use and psychiatric disorders in a nationally representative sample of women.

Authors:  Keely Cheslack-Postava; Katherine M Keyes; Sarah R Lowe; Karestan C Koenen
Journal:  Arch Womens Ment Health       Date:  2014-08-13       Impact factor: 3.633

3.  Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.

Authors:  Julia Potter; Jean Bouyer; James Trussell; Caroline Moreau
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

4.  Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression.

Authors:  Elizabeth A Young; Susan G Kornstein; Anne T Harvey; Stephen R Wisniewski; Jennifer Barkin; Maurizio Fava; Madhukar H Trivedi; A John Rush
Journal:  Psychoneuroendocrinology       Date:  2007-07-16       Impact factor: 4.905

5.  Factors predicting mood changes in oral contraceptive pill users.

Authors:  Ghodratollah Shakerinejad; Alireza Hidarnia; Mohammad Esmaeil Motlagh; Khodabakhsh Karami; Shamsoddin Niknami; Ali Montazeri
Journal:  Reprod Health       Date:  2013-09-09       Impact factor: 3.223

Review 6.  Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review.

Authors:  Ariel B Handy; Shelly F Greenfield; Kimberly A Yonkers; Laura A Payne
Journal:  Harv Rev Psychiatry       Date:  2022 Mar-Apr 01       Impact factor: 3.732

Review 7.  Hormonal contraception and mood disorders.

Authors:  Eveline Mu; Jayashri Kulkarni
Journal:  Aust Prescr       Date:  2022-06-01

8.  Evaluation of sensitivity, motor and pain thresholds across the menstrual cycle through medium-frequency transcutaneous electrical nerve stimulation.

Authors:  Mariana de Brito Barbosa; Elaine Caldeira de Oliveira Guirro; Fabiana Roberta Nunes
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.